San Diego, CA, United States of America

David A Canton

This inventor holds 1 USPTO granted patent. Top assignee: Grand Decade Developments Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David A Canton. Retrieved from https://idiyas.com/inventor/david-a-canton-e0d6gv7d

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David A. Canton: Innovator in Cancer Treatment

Introduction

David A. Canton is a notable inventor based in San Diego, California. He has made significant contributions to the field of cancer treatment through his innovative work. His dedication to research and development has led to advancements that could potentially improve patient outcomes.

Latest Patents

David A. Canton holds a patent for "Plasmid Constructs for Treating Cancer and Methods of Use." This patent represents a crucial step in the ongoing battle against cancer, showcasing his commitment to finding effective solutions for this challenging disease. He has 1 patent to his name, reflecting his focused efforts in this specialized area.

Career Highlights

Canton is associated with Grand Decade Developments Limited, where he continues to work on groundbreaking projects. His role in the company allows him to collaborate with other talented professionals in the field, further enhancing his contributions to cancer research.

Collaborations

Some of his notable coworkers include Anandaroop Mukhopadhyay and Christopher Twitty. Their collective expertise fosters an environment of innovation and creativity, which is essential for advancing medical research.

Conclusion

David A. Canton is a dedicated inventor whose work in cancer treatment exemplifies the impact of innovation in healthcare. His contributions are paving the way for new methods of treatment that could benefit many patients in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…